| Literature DB >> 31456855 |
Hyeon-Gi Kim1, A Ram Yu2, Jae Joon Lee2, Yong-Jin Lee1, Sang Moo Lim1,3, Jin Su Kim1,4.
Abstract
Tumor interstitial pressure is a fundamental feature of cancer biology. Elevation in tumor pressure affects the efficacy of cancer treatment and results in the heterogenous intratumoral distribution of drugs and macromolecules. Monoclonal antibodies (mAb) play a prominent role in cancer therapy and molecular nuclear imaging. Therapy using mAb labeled with radionuclides-also known as radioimmunotherapy (RIT)-is an effective form of cancer treatment. RIT is clinically effective for the treatment of lymphoma and other blood cancers; however, its clinical use for solid tumor was limited because their high interstitial pressure prevents mAb from penetrating into the tumor. This pressure can be decreased using anti-cancer drugs or additional external therapy. In this paper, we reviewed the intratumoral pressure using direct tumor-pressure measurement strategies, such as the wick-in-needle and pressure catheter transducer method, and indirect tumor-pressure measurement strategies via magnetic resonance.Entities:
Keywords: ADC; Monoclonal antibody; Radioimmunotherapy; Tumor pressure
Year: 2019 PMID: 31456855 PMCID: PMC6694369 DOI: 10.1007/s13139-019-00598-7
Source DB: PubMed Journal: Nucl Med Mol Imaging ISSN: 1869-3474
Fig. 1Cartoon representation of the total tissue pressure. The wick-in-needle (WN) method can only measure the interstitial stress. The pressure catheter (PC) method, however, can measure total tissue pressure (interstitial stress + solid stress)
Fig. 2Typical pressure-measurement systems
Fig. 3Representative example of an apparent diffusion coefficient (ADC) map. Image of a mouse bearing NCI-N87 human gastric cancer
Drugs known to reduce tumor IFP
| Target | Drug or method | Description | Ref |
|---|---|---|---|
| HA | PEGPH20 | Degradation of HA | [ |
| Angiotensin receptor | Losartan | Inhibition of HA and collagen | [ |
| Collagen | Collagenase | Degradation of collagen | [ |
| VEGFR | Bevacizumab | Normalization of blood vessels, improved blood flow | [ |